ATE71372T1 - Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel. - Google Patents

Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel.

Info

Publication number
ATE71372T1
ATE71372T1 AT88112722T AT88112722T ATE71372T1 AT E71372 T1 ATE71372 T1 AT E71372T1 AT 88112722 T AT88112722 T AT 88112722T AT 88112722 T AT88112722 T AT 88112722T AT E71372 T1 ATE71372 T1 AT E71372T1
Authority
AT
Austria
Prior art keywords
active ingredient
agent containing
benzothiazole derivative
rheumatic agent
benzothiazole
Prior art date
Application number
AT88112722T
Other languages
German (de)
English (en)
Inventor
Atsushi Imamura
Noriyuki Hori
Tadayuki Saito
Noriyasu Nishimura
Masami Ohashi
Kohichiro Yoshino
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of ATE71372T1 publication Critical patent/ATE71372T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT88112722T 1987-08-07 1988-08-04 Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel. ATE71372T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62198669A JPH0670025B2 (ja) 1987-08-07 1987-08-07 ベンゾチアゾ−ル誘導体および該化合物を有効成分とする抗リウマチ剤
EP88112722A EP0306708B1 (en) 1987-08-07 1988-08-04 Novel benzothiazole and antirheumatic agent comprising it as an active ingredient

Publications (1)

Publication Number Publication Date
ATE71372T1 true ATE71372T1 (de) 1992-01-15

Family

ID=16395075

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88112722T ATE71372T1 (de) 1987-08-07 1988-08-04 Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel.

Country Status (8)

Country Link
US (1) US4910211A (OSRAM)
EP (1) EP0306708B1 (OSRAM)
JP (1) JPH0670025B2 (OSRAM)
KR (1) KR930009790B1 (OSRAM)
AT (1) ATE71372T1 (OSRAM)
DE (1) DE3867572D1 (OSRAM)
ES (1) ES2039522T3 (OSRAM)
GR (1) GR3004018T3 (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428052A (en) * 1984-09-19 1995-06-27 Centre Internationale De Recherches Dermatologiques (C.I.R.D.) Aromatic heterocyclic derivatives and their therapeutic and cosmetic use
US5260295A (en) * 1984-09-19 1993-11-09 Centre International De Recherches Dermatologiques (C.I.R.D.) Aromatic heterocyclic derivatives and their therapeutic and cosmetic use
JP3169216B2 (ja) * 1988-07-08 2001-05-21 プロメガ・バイオサイエンシーズ・インコーポレイテッド 蛍光性ベンゾチアゾール誘導体の製法及び用途
US5254692A (en) * 1990-04-06 1993-10-19 Bayer Aktiengesellschaft 2,6-dialkyl-4-(benzothiazol- or benzoxazol-7-yl)-1,4-dihydropyridines
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
ATE248153T1 (de) * 1994-10-12 2003-09-15 Euro Celtique Sa Neue benzoxazole
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
AU4527996A (en) * 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0814809B1 (en) * 1994-12-13 2003-08-13 Euroceltique S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US6013659A (en) * 1998-09-04 2000-01-11 University Of Pittsburgh Methods of reducing tumor colony number using novel benzothiazole compounds
JP2004524289A (ja) * 2000-12-22 2004-08-12 アストラゼネカ・アクチエボラーグ 治療化合物
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
AU2002353739A1 (en) * 2001-11-28 2003-06-10 Astrazeneca Ab Therapeutic compounds
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
AU2003208525B9 (en) * 2002-02-04 2009-08-27 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
CN101172983A (zh) 2002-03-20 2008-05-07 麦它波莱克斯股份有限公司 取代的苯乙酸
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
WO2005013691A1 (en) * 2003-08-04 2005-02-17 Hemocorm Limited Use of boranocarbonates for the therapeutic delivery of carbon monoxide
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
EP1751120A4 (en) * 2004-05-25 2010-05-05 Metabolex Inc SUBSTITUTED TRIAZOLE AS PPAR MODULATORS AND MANUFACTURING METHOD THEREFOR
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US7714131B2 (en) 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
PT2699242T (pt) 2011-04-19 2018-01-22 Alfama Inc Moléculas de libertação de monóxido de carbono e utilizações das mesmas
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドAlfama,Inc. 一酸化ルテニウム放出分子およびその使用
WO2020142865A1 (zh) * 2019-01-07 2020-07-16 江苏凯迪恩医药科技有限公司 一种苯甲酰胺类化合物、中间体、制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035757A1 (en) * 1969-02-25 1970-12-24 Roussel Uclaf Novel 4-carboxy-4,5,6,7-tetrahydro benzothia- - zole derivs
US3816443A (en) * 1972-02-17 1974-06-11 Merck & Co Inc 4-(benzothiazol-2-yl)fluoro phenyl-acetic acids
US3895028A (en) * 1972-09-12 1975-07-15 Tokyo Tanabe Co Alpha-(2-phenylbenzothiazol-5-yl)propionic acid
JPS59121704A (ja) * 1982-12-28 1984-07-13 三菱電線工業株式会社 耐水トリ−性電気絶縁性組成物

Also Published As

Publication number Publication date
EP0306708A1 (en) 1989-03-15
US4910211A (en) 1990-03-20
JPH0670025B2 (ja) 1994-09-07
KR890003720A (ko) 1989-04-17
KR930009790B1 (ko) 1993-10-11
EP0306708B1 (en) 1992-01-08
JPS6442476A (en) 1989-02-14
GR3004018T3 (OSRAM) 1993-03-31
ES2039522T3 (es) 1993-10-01
DE3867572D1 (de) 1992-02-20

Similar Documents

Publication Publication Date Title
ATE71372T1 (de) Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel.
ATE133945T1 (de) 3,5-di-tertiärbutyl-4- hydroxyphenylmethylenderivate von 2- substituierten thiazolidinonen, oxazolidinonen und imidazolidinonen als antientzündlich wirkende mittel
DE69331774D1 (de) 7-Substituierte-8-substituierte-9-substituierte Amino-7-Demethyl-6-Deoxy-Tetracycline als antibiotische Mittel
ATE183182T1 (de) S-triazinderivate als lichtschutzmittel
DK205789D0 (da) Optisk aktive pyridoncarboxylsyrederivater og laegemidler indeholdende disse
DE69221309D1 (de) Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer
NO932607D0 (no) Piperidinderivater og anvendelse av disse
IT1224416B (it) Chelanti macrociclici e loro chelati
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
FI935777A0 (fi) Inhibitorer foer HIV-proteas anvaendbara vid behandling av AIDS
DE69126758D1 (de) Benzamid-Derivate
DE69825977D1 (de) Antivirale mittel
DE3862791D1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
EA199900888A1 (ru) Противоревматические средства
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
ATE84303T1 (de) Cysteinderivate.
DE69533573D1 (de) Anxiolytischer wirkstoff
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
DK656889A (da) Azabicykliske derivater
DE3867494D1 (de) Fluor enthaltende vitamin-d2-derivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee